Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_assertion type Assertion NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_head.
- NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_assertion description "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_provenance.
- NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_assertion evidence source_evidence_literature NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_provenance.
- NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_assertion SIO_000772 23354806 NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_provenance.
- NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_assertion wasDerivedFrom befree-20150227 NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_provenance.
- NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_assertion wasGeneratedBy ECO_0000203 NP243057.RA-ljmH8st3vrthTe7aU2YsuavFZrHAhPqXRX1QT-2FXk130_provenance.